We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
+12.31%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$1.4B
AUM Growth
-$103M
Cap. Flow
-$192M
Cap. Flow %
-13.74%
Top 10 Hldgs %
58.28%
Holding
52
New
10
Increased
7
Reduced
7
Closed
17

Top Buys

Rank Stock Value
1
CYBX
CYBERONICS INC
CYBX
+$45.7M
2
ABBV icon
AbbVie
ABBV
+$45.3M
3
SEM
Select Medical
SEM
+$41.6M
4
ARNA
Arena Pharmaceuticals Inc
ARNA
+$34.9M
5
MDCO
Medicines Co
MDCO
+$33.1M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$74.8M
2
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$45.6M
3
VTRS icon
Viatris
VTRS
+$42.3M
4
CNMD icon
CONMED
CNMD
+$35M
5
BSX icon
Boston Scientific
BSX
+$33.1M

Sector Composition

Rank Sector Weight
1 Healthcare 62.03%
2 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VOLC
51
DELISTED
VOLCANO CORPORATION COM STK
VOLC
– –
-2,550,000
Closed -$45.6M
1 2
3

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Camber Capital Management held 52 positions worth $1.4B, down 6.9% from $1.5B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Camber Capital Management withdrew a net $192M in Q1 2015, closing 17 positions and reducing 7 holdings. Its most notable exit was GSK, an estimated $74.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 59% a quarter earlier, followed by Consumer Discretionary.

Against the trend, Camber Capital Management opened a new position in CYBERONICS INC worth $48.7M.

  • Camber Capital Management's largest Q1 2015 buy was CYBERONICS INC: 750,000 shares worth $48.7M.
  • Camber Capital Management added most to Medicines Co in Q1 2015, an estimated $33.1M increase.
  • Camber Capital Management's biggest Q1 2015 reduction was CONMED, cutting an estimated $35M.
  • Camber Capital Management fully exited GSK in Q1 2015, selling an estimated $74.8M.
  • Camber Capital Management's ten largest holdings make up 58% of its $1.4B portfolio in Q1 2015.
  • Camber Capital Management opened 10 new positions and closed 17 in Q1 2015.
  • Camber Capital Management's portfolio value fell 6.9% quarter-over-quarter to $1.4B.

Based on Camber Capital Management's 13F filing for Q1 2015, filed 15 May 2015.